Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,674
archived clinical trials in
Skin Cancer

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. James Healthcare Cancer Care
mi
from
Butte, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. James Healthcare Cancer Care
mi
from
Butte, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Clinical Research Facility
mi
from
Great Falls, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Clinical Research Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Peter's Hospital
mi
from
Helena, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Peter's Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Community Medical Center
mi
from
Missoula, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Community Medical Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Montana Cancer Center
mi
from
Missoula, MT
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Immanuel Medical Center
mi
from
Omaha, NE
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Creighton University Medical Center
mi
from
Omaha, NE
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Rutherford Hospital
mi
from
Rutherfordton, NC
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Rutherford Hospital
mi
from
Rutherfordton, NC
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Sanford Broadway Clinic
mi
from
Fargo, ND
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Sanford Broadway Clinic
mi
from
Fargo, ND
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Altru Cancer Center at Altru Hospital
mi
from
Grand Forks, ND
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Altru Cancer Center at Altru Hospital
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Adena Regional Medical Center
mi
from
Chillicothe, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Adena Regional Medical Center
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Riverside Methodist Hospital Cancer Care
mi
from
Columbus, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Riverside Methodist Hospital Cancer Care
mi
from
Columbus, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Columbus
mi
from
Columbus, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Grant Medical Center Cancer Care
mi
from
Columbus, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Grant Medical Center Cancer Care
mi
from
Columbus, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mount Carmel West Hospital
mi
from
Columbus, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mount Carmel West Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Doctors Hospital at Ohio Health
mi
from
Columbus, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Doctors Hospital at Ohio Health
mi
from
Columbus, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Grandview Hospital
mi
from
Dayton, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Dayton
mi
from
Dayton, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Grady Memorial Hospital
mi
from
Delaware, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Grady Memorial Hospital
mi
from
Delaware, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Middletown Regional Hospital
mi
from
Franklin, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Middletown Regional Hospital
mi
from
Franklin, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Fairfield Medical Center
mi
from
Lancaster, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Fairfield Medical Center
mi
from
Lancaster, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mercy Medical Center
mi
from
Springfield, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mercy Medical Center
mi
from
Springfield, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Community Hospital of Springfield and Clark County
mi
from
Springfield, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Community Hospital of Springfield and Clark County
mi
from
Springfield, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
UVMC Cancer Care Center at Upper Valley Medical Center
mi
from
Troy, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
UVMC Cancer Care Center at Upper Valley Medical Center
mi
from
Troy, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mount Carmel St. Ann's Cancer Center
mi
from
Westerville, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mount Carmel St. Ann's Cancer Center
mi
from
Westerville, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Clinton Memorial Hospital
mi
from
Wilmington, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Clinton Memorial Hospital
mi
from
Wilmington, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Click here to add this to my saved trials